CCR5 neurons express C-C chemokine receptor type 5 (CCR5), a G protein-coupled receptor (GPCR) that responds to inflammatory chemokines including CCL3 (MIP-1α), CCL4 (MIP-1β), and CCL5 (RANTES). These neurons play important roles in neuroinflammation, synaptic modulation, and the brain's immune response to injury and disease.
CCR5-expressing neurons are found in multiple brain regions:
- Cerebral Cortex - Layer 2/3 and Layer 5 pyramidal neurons
- Hippocampus - CA1 and CA3 pyramidal neurons, dentate gyrus granule cells
- Basal Ganglia - Striatal medium spiny neurons
- Amygdala - Neurons in basal and lateral nuclei
- Thalamus - Various thalamic nuclei
- Cerebellum - Purkinje cells and granule cells
CCR5 is a Gαi-coupled GPCR that responds to inflammatory chemokines:
- CCL3 (MIP-1α) - Pro-inflammatory chemokine, elevated in neuroinflammation
- CCL4 (MIP-1β) - Ligand for CCR5, modulates neuronal activity
- CCL5 (RANTES) - Chemotactic protein, affects synaptic transmission
Upon CCR5 activation:
- Gαi signaling - Inhibits adenylate cyclase, reduces cAMP
- MAPK pathway - Activates ERK1/2 signaling
- PI3K/Akt pathway - Promotes cell survival
- Calcium signaling - Modulates intracellular calcium levels
CCR5 neurons respond to and modulate neuroinflammation:
- Chemokine production - Produce inflammatory mediators in response to activation
- Microglial communication - Cross-talk with microglia via chemokine signaling
- Astrocyte interaction - Bidirectional signaling with astrocytes
CCR5 modulates synaptic function:
- Presynaptic modulation - Alters neurotransmitter release probability
- Postsynaptic effects - Modifies receptor sensitivity
- Plasticity - Affects long-term potentiation (LTP) and depression (LTD)
CCR5 signaling is involved in injury responses:
- Stroke - CCL5/CCR5 axis is activated following ischemic injury
- Traumatic brain injury - Chemokine-mediated neuroinflammation
- Neurodegeneration - Altered expression in disease states
CCR5 receptor activation modulates neuronal excitability:
- Hyperpolarization - Often causes membrane hyperpolarization via GIRK channels
- Reduced firing - Generally inhibitory effect on action potential generation
- Synaptic depression - Reduces excitatory synaptic transmission
- Plasticity impairment - Can impair LTP induction
CCR5-expressing neurons connect with:
- Local circuits - Intracortical connections
- Subcortical structures - Thalamic inputs, basal ganglia outputs
- Glial cells - Microglial and astrocytic processes
- Immune cells - Perivascular macrophages, infiltrating immune cells
CCR5 is implicated in AD pathogenesis:
- Elevated expression - CCR5 is upregulated in AD brains
- Amyloid interaction - Aβ modulates CCR5 signaling
- Neuroinflammation - CCL5/CCR5 axis promotes neuroinflammation
- Cognitive decline - Genetic variants (CCR5-Δ32) affect cognitive decline
- Therapeutic potential - CCR5 antagonists as potential treatments
In PD:
- Dopaminergic neurons - CCR5 expressed on substantia nigra pars compacta neurons
- Neuroinflammation - Elevated CCL5 in PD brains
- Microglial activation - CCR5 mediates microglial recruitment
- Therapeutic targeting - CCR5 blockade may be protective
CCR5 plays a role in MS:
- T-cell recruitment - CCR5 guides immune cell infiltration
- Demyelination - Contributes to inflammatory demyelination
- Therapeutic targeting - CCR5 antagonists (e.g., maraviroc) used in trials
In ischemic stroke:
- Reperfusion injury - CCL5/CCR5 contributes to post-stroke inflammation
- Neuroprotection - CCR5 antagonists reduce infarct size
- Rehabilitation - CCR5 affects post-stroke recovery
¶ HIV-Associated Neurocognitive Disorders (HAND)
CCR5 is the primary co-receptor for HIV entry:
- Viral entry - HIV-1 uses CCR5 to enter macrophages and microglia
- Neurotoxicity - Viral proteins cause neuronal dysfunction
- Antiretroviral therapy - CCR5 antagonists (maraviroc) used in treatment
Targeting CCR5 offers therapeutic opportunities:
- CCR5 antagonists - Maraviroc, vicriviroc for HIV and potentially neuroprotection
- Modulation of neuroinflammation - Downregulating CCR5 signaling
- Cognitive enhancement - CCR5 genetic variants affect cognition
- Stroke treatment - CCR5 blockade as neuroprotective strategy
Key approaches for studying CCR5 neurons:
- Molecular biology - qPCR, Western blot, RNA-seq
- Histochemistry - CCR5 antibody staining with neuronal markers
- Calcium imaging - Functional calcium signaling studies
- Electrophysiology - Patch-clamp recordings
- Behavior - Cognitive testing in CCR5 knockout mice
- CCR5 in Alzheimer's disease (2019)
- Chemokine receptors in neurodegeneration (2020)
- CCR5 and synaptic plasticity (2018)
- HIV-associated neurocognitive disorders (2021)
- CCR5 in stroke pathophysiology (2020)